Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor

Science Advances
Yuan WangJie Yang

Abstract

SND1 is highly expressed in various cancers. Here, we identify oncoprotein SND1 as a previously unidentified endoplasmic reticulum (ER) membrane-associated protein. The amino-terminal peptide of SND1 predominantly associates with SEC61A, which anchors on ER membrane. The SN domain of SND1 catches and guides the nascent synthesized heavy chain (HC) of MHC-I to ER-associated degradation (ERAD), hindering the normal assembly of MHC-I in the ER lumen. In mice model bearing tumors, especially in transgenic OT-I mice, deletion of SND1 promotes the presentation of MHC-I in both B16F10 and MC38 cells, and the infiltration of CD8+ T cells is notably increased in tumor tissue. It was further confirmed that SND1 impaired tumor antigen presentation to cytotoxic CD8+ T cells both in vivo and in vitro. These findings reveal SND1 as a novel ER-associated protein facilitating immune evasion of tumor cells through redirecting HC to ERAD pathway that consequently interrupts antigen presentation.

References

Jan 1, 1995·Cold Spring Harbor Symposia on Quantitative Biology·B K SadasivanP Cresswell
Oct 23, 2001·Advances in Cancer Research·F Garrido, I Algarra
Apr 3, 2002·Seminars in Cancer Biology·Barbara SeligerSoldano Ferrone
Jan 22, 2003·Cancer Immunology, Immunotherapy : CII·Teresa CabreraFederico Garrido
Jun 6, 2003·Biochimica Et Biophysica Acta·Kajsa Paulsson, Ping Wang
Apr 28, 2009·BMC Medical Genomics·Hideaki MizunoAkinori Sarai
Feb 3, 2012·Nature Cell Biology·Hemmo MeyerSebastian Bremer
Jul 24, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Jie YinJie Yang
Aug 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Marian L BurrPaul J Lehner
Jul 18, 2014·Proceedings of the National Academy of Sciences of the United States of America·Dick J H van den BoomenPaul J Lehner
Nov 19, 2014·International Journal of Oncology·Nidhi JariwalaDevanand Sarkar
Dec 5, 2014·International Journal of Cancer. Journal International Du Cancer·Federico GarridoAngel M Garcia-Lora
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory L Beatty, Whitney L Gladney
Apr 15, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kazuharu KukitaNoriyuki Sato
Jul 27, 2015·Molecular Immunology·D J H van den Boomen, P J Lehner
Aug 9, 2015·Molecular Cell·Daisuke Morito, Kazuhiro Nagata
Jan 23, 2016·Current Opinion in Immunology·Federico GarridoThorbald van Hall
Aug 12, 2016·Journal of Computational Chemistry·Changhao WangRay Luo
Oct 19, 2016·Cell Death and Differentiation·Emilio Gutierrez-BeltranPeter V Bozhkov
Oct 28, 2016·International Journal of Cancer. Journal International Du Cancer·Francisco PereaFrancisco Ruiz-Cabello
Dec 3, 2016·Cell·Toshiro MoroishiKun-Liang Guan
Dec 10, 2016·Trends in Biochemical Sciences·Karin Römisch
Jan 4, 2017·Cancer Immunology, Immunotherapy : CII·Federico GarridoNatalia Aptsiauri
Apr 22, 2017·Cancer Research·Nidhi JariwalaDevanand Sarkar
Mar 24, 2018·Current Opinion in Immunology·Natalia AptsiauriFederico Garrido
Dec 5, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lingbiao XinJie Yang
Jan 9, 2019·Frontiers in Oncology·Begoña OchoaMaría José Martínez

❮ Previous
Next ❯

Methods Mentioned

BETA
affinity purification
proximity ligation assay
pull-down
Co-IP
Immunoprecipitation
confocal microscopy
flow cytometry
glycosylation
electrophoresis
transgenic

Software Mentioned

KDEL
Co
GFG
GraphPad Prism
IP
Gromacs
TASSER
ZDOCK

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.